title: Intravitreal dexamethasone implant (ozurdex) in coats' disease.
abstract: We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats' disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular pressure moderately rose in a temporary fashion. The dexamethasone implant seems to be a valuable addition to the armamentarium of treatment options for Coats' disease as it necessitates fewer injections than anti-VEGF injections and thereby fewer sessions of general anesthesia in the pediatric population.
authors.affiliation: Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey.
authors.forename: Ali Osman
authors.initials: AO
authors.lastname: Saatci
authors.forename: Hasan Can
authors.initials: HC
authors.lastname: Doruk
authors.forename: Aylin
authors.initials: A
authors.lastname: Yaman
keywords: Coats’ disease; Dexamethasone implant; Laser photocoagulation; Ranibizumab